Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis

N. Çakici, Mariska Bot, F. Lamers, Thomas Janssen, Peter J. van der Spek, Lieuwe de Haan, Sabine Bahn, Brenda W.J.H. Penninx, Nico J.M. van Beveren

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Scopus)

Abstract

We investigated whether there are similar serum alterations in schizophrenia and major depressive disorder (MDD). We investigated serum analytes in two epidemiological studies on schizophrenia (N = 121) and MDD (N = 1172) versus controls. Serum analytes (N = 109) were measured with a multi-analyte profiling platform and analysed using linear regression models, adjusted for site, age, gender, ethnicity, anti-inflammatory agents, smoking, cardiovascular disease and diabetes, and adjusted for multiple comparisons. An increase in leptin and insulin levels was observed for both schizophrenia patients (Cohen's d (d): 0.26 and 0.65, respectively) and MDD patients (d: 0.29 and 0.12, respectively) compared to their respective controls. Lower angiopoietin-2 levels were seen in both schizophrenia (d: -0.22) and MDD (d: -0.13). Four analytes differed in only schizophrenia patients (increased levels of C-peptide and prolactin, and decreased levels of CD5 antigen-like and sex hormone binding globulin) and one analyte differed in only MDD patients (increased angiotensinogen levels) compared to their respective controls. Restricting analyses to patients with a current episode of disease showed even more marked elevations of insulin and leptin. Our results suggest the presence of insulin and leptin resistance as cross-disorder mechanisms that could contribute to the higher somatic comorbidity and decreased life-span seen in both disorders.

Original languageEnglish
Pages (from-to)835-846
Number of pages12
JournalEuropean neuropsychopharmacology
Volume29
Issue number7
DOIs
Publication statusPublished - 1 Jul 2019

Keywords

  • Cross-disorder
  • Depressive disorder
  • Insulin resistance
  • Leptin
  • Proteomics
  • Schizophrenia

Cite this